Bluesight Partners with GraphiteRx & Mark Cuban Cost Plus Drugs To Expand Access To Cost-Saving Medication Sources

Bluesight and GraphiteRx announced a partnership that integrates marketplace data, including pricing from Mark Cuban Cost Plus Drugs, into Bluesight's CostCheck and ShortageCheck platforms. The integration gives hospital pharmacy teams access to alternative medication suppliers alongside traditional wholesaler options, helping to reduce drug costs and address supply shortages.

Through the partnership, Bluesight customers can compare Cost Plus Drugs pricing with other suppliers within their existing procurement workflows, with no volume commitments required. Pharmacy teams can evaluate options by price, availability, or clinical need, and access additional supply channels when traditional distributors face constraints.

Bluesight provides inventory management, procurement, and . . .